Groupe pharmaceutique · Allemagne
Fresenius
Un groupe de 53 sociétés, avec 1 470 médicaments dans 13 pays.
Structure du groupe
53 sociétés dans 20 pays
Chargement de votre page…
Chargement de votre page…
Groupe pharmaceutique · Allemagne
Un groupe de 53 sociétés, avec 1 470 médicaments dans 13 pays.
53 sociétés dans 20 pays
Un compte gratuit pour les apps Prognia : Ward pour réviser, Osler pour des réponses cliniques avec leurs sources, et le réseau pour retrouver vos collègues.
Les groupes sont constitués par Prognia à partir des noms publiés par les autorités et des liens entre sociétés ; ils ne reflètent pas une structure juridique officielle.
Tous les médicaments de toutes les sociétés du groupe, les actuels d’abord.
1–25 sur 1 470
| Médicament | Substance active | Pays | Statut | Autorisation |
|---|---|---|---|---|
| 0.9% SODIUM CHLORIDE INJECTION900 mg / 100 ml · Solution | Sodium chloride | Canada | Commercialisé | 2013 |
| 2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION20 mg / ml · Solution | Calcium gluconate | Canada | Commercialisé | 2025 |
| 5% DEXTROSE INJECTION50 mg / ml · Solution | Dextrose | Canada | Commercialisé | 2014 |
| ACETAMINOPHEN1gm/100ml (10mg/ml) | 500mg/50ml (10mg/ml) | 650mg/65ml (10mg/ml) · Solution | Paracetamol | États-Unis | Commercialisé | 2015 |
| ACETATO SODICO 1M FRESENIUS KABI CONCENTRADO PARA SOLUCION PARA PERFUSION1361 mg · Solución inyectable | Sodium acetate | Espagne | Commercialisé | 2001 |
| ácido zoledrônico | Zoledronic acid | Brésil | Autorisé | 2019 |
| ACIDO ZOLEDRONICO FRESENIUS KABIConcentrato per soluzione per infusione | Zoledronic acid | Italie | Autorisé | |
| ACIDO ZOLEDRONICO KABI 4MG/5ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG0,80 mg · Concentrado para solución para perfusión | Zoledronic acid | Espagne | Commercialisé | 2013 |
| ACQUA PER PREPARAZIONI INIETTABILI FKISoluzione iniettabile | Acqua preparazioni iniettabili | Italie | Autorisé | |
| ACQUA PER PREPARAZIONI INIETTABILI FKISoluzione iniettabile | Acqua preparazioni iniettabili | Italie | Autorisé | |
| ACYCLOVIR SODIUM INJECTION50 mg / ml · Solution | Aciclovir | Canada | Commercialisé | 1998 |
| ADDAMEL NConcentrato per soluzione per infusione | Cromo, Rame, Ferrous, Manganese, Potassio ioduro, Fluoride, Technetium (99m tc) pertechnetate, Selenium, Zinc | Italie | Autorisé | |
| ADDAVEN | Cloreto zinco, Cloreto férrico, Fluoreto, Cloreto cúprico, Dicloreto manganês, Selenium, Iodeto, Cloreto crômico, Technetium (99m tc) pertechnetate | Brésil | Autorisé | 2020 |
| ADDAVEN CONCENTRATE FOR SOLUTION FOR INFUSION5.33 mcg/ml + 102.3 mcg/ml + 540 mcg/ml + 19.79 mcg/ml + 16.6 mcg/ml + 210 mcg/ml + 4.85 mcg/ml + 17.29 mcg/ml + 1050 mcg/ml · Infusion, solution concentrate | Chromic, Copper, Ferric citrate, Manganese, Potassium iodide, Fluoride, Technetium (99m tc) pertechnetate, Selenium, Zinc | Singapour | Autorisé | 2017 |
| ADDNUTRIV10 mcg / 10 ml + 380 mcg / 10 ml + 950 mcg / 10 ml + 130 mcg / 10 ml + 1100 mcg / 10 ml + 55 mcg / 10 ml + 19 mcg / 10 ml + 79 mcg / 10 ml + 5000 mcg / 10 ml · Solution | Chromium, Copper, Fluoride, Iodine, Iron, Manganese, Molybdenum, Selenium, Zinc | Canada | Commercialisé | 2020 |
| ADENOSINA KABISoluzione iniettabile | Adenosine | Italie | Autorisé | |
| ADENOSINA KABI 3 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADA3 mg · Solución inyectable en jeringa precargada | Adenosine | Espagne | Commercialisé | 2017 |
| Adenosine Fresenius Kabi 3 mg/ml, oplossing voor injectie in een voorgevulde spuitOplossing voor injectie | Adenosine | Pays-Bas | Autorisé | 2015 |
| ADENOSINE INJECTION3 mg / ml · Solution | Adenosine | Canada | Commercialisé | 2017 |
| ADENOSINE INJECTION3 mg / ml · Solution | Adenosine | Canada | Commercialisé | 2017 |
| ADENOSINE INJECTION3 mg / ml · Solution | Adenosine | Canada | Commercialisé | 2007 |
| ADRIM – DOXORUBICIN HYDROCHLORIDE INJECTION USP 2MG/ML2 mg/ml · Injection, solution | Doxorubicin | Singapour | Autorisé | 2021 |
| ÁGUA PARA INJEÇÃO | Água para injetáveis, Água para injeção | Brésil | Autorisé | 2004 |
| AGUA PARA PREPARACIONES INYECTABLES FRESENIUS KABI DISOLVENTE PARA USO PARENTERAL100 ml · Disolvente para uso parenteral | Agua para preparaciones inyectables | Espagne | Commercialisé | 2001 |
| AGUA PARA PREPARACIONES INYECTABLES MEINSOL, DISOLVENTE PARA USO PARENTERAL100 ml · Disolvente para uso parenteral | Agua para preparaciones inyectables | Espagne | Commercialisé | 1990 |
Où ses médicaments sont enregistrés ou fabriqués, et combien sont actuels.
| Pays | Médicaments | Actuels | Anciens | Sociétés |
|---|---|---|---|---|
| Canada | 223 | 167 | 56 | SociétésTous les médicaments |
| Espagne | 212 | 161 | 51 | SociétésTous les médicaments |
| Brésil | 198 | 71 | 127 | SociétésTous les médicaments |
| Pays-Bas | 188 | 188 | 0 | SociétésTous les médicaments |
| États-Unis | 138 | 136 | 2 | SociétésTous les médicaments |
| Serbie | 115 | 107 | 8 | SociétésTous les médicaments |
| Roumanie | 97 | 0 | 97 | SociétésTous les médicaments |
| Italie | 92 | 92 | 0 | SociétésTous les médicaments |
| Croatie | 69 | 69 | 0 | SociétésTous les médicaments |
| Singapour | 67 | 67 | 0 | SociétésTous les médicaments |
| Arabie saoudite | 32 | 32 | 0 | SociétésTous les médicaments |
| Taïwan | 26 | 7 | 19 | SociétésTous les médicaments |
| Union européenne (EMA) | 13 | 12 | 1 | SociétésTous les médicaments |
Également dans les registres : France, Royaume-Uni
Les groupes ATC auxquels appartiennent la plupart de ses médicaments, les plus importants d’abord.
Les substances actives présentes dans la plupart de ses médicaments.
Comment les registres l’écrivent, normalisé : sans forme juridique, accents ni majuscules.
Compilé par Prognia à partir des registres publics de médicaments et d’entreprises ci-dessous. Aucun logo n’est utilisé.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence : EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence : AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence : Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence : Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence : Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence : Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence : Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence : Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence : Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence : AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence : AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence : BDPM exact Licence Ouverte v1.0 (October 2011)
INSEE (www.insee.fr), via DINUM API Recherche d’entreprises; include original record update date and retrieval date
Licence : Licence Ouverte / Open Licence
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence : Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence : Open Government Licence v3.0; exact Crown copyright 2026 publication grant
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licence : CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence : Otvorena dozvola RH
Contains Irish Public Sector Data licensed under Creative Commons Attribution 4.0 International (CC BY 4.0), Companies Registration Office; original dataset/API URL and company number, exact locator/source version and retrieval date; selected field normalization by Prognia. https://creativecommons.org/licenses/by/4.0/
Licence : Creative Commons Attribution
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licence : Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence : Italian Open Data Licence
State Enterprise Centre of Registers / Valstybės įmonė Registrų centras; source dataset/resource URL, exact original code/UUID/revision, original CSV ordinal, retrieval time; CC BY 4.0 https://creativecommons.org/licenses/by/4.0/ ; selected field normalization by Prognia.
Licence : Creative Commons Attribution
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence : Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brønnøysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Licence : Norwegian Licence for Open Government Data
Ministerstwo Sprawiedliwości / Krajowy Rejestr Sądowy; original source URL, literal IDs and source locators, original creation/snapshot dates where present and acquisition time; selected fields normalized by Prognia; original statutory/MOJ reuse conditions
Licence : Statutory public-register API reuse with attribution conditions
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence : Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence : Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence : Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence : Singapore Open Data Licence
TFDA, dataset 9122, Government Open Data Licence 1.0; source update and retrieval dates
Licence : Taiwan Government Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence : FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Signaler une erreur ou demander un retraitLes corrections de la société elle-même sont les bienvenues.
Fresenius : veillez à l’exactitude de vos médicaments sur Prognia, voyez comment les professionnels les utilisent et répondez à leurs questions. Un appel de 20 minutes, en anglais.
Réserver un appelDes groupes pharmaceutiques connus, chacun avec toutes ses sociétés.
Classés selon leur nombre de médicaments.